131 related articles for article (PubMed ID: 24336822)
1. Preventing malaria in HIV-infected pregnant women.
Bulterys PL; Kaplan JE; Gutman J
Clin Infect Dis; 2014 Mar; 58(5):660-2. PubMed ID: 24336822
[No Abstract] [Full Text] [Related]
2. Is cotrimoxazole prophylaxis effective to prevent malaria in HIV-infected pregnant women?
Denoeud-Ndam L; Briand V; Zannou DM; Girard PM; Cot M
Clin Infect Dis; 2014 Aug; 59(4):603-4. PubMed ID: 24771502
[No Abstract] [Full Text] [Related]
3. Reply to Denoeud-Ndam et al.
Klement E; Caumes E
Clin Infect Dis; 2014 Aug; 59(4):604. PubMed ID: 24771501
[No Abstract] [Full Text] [Related]
4. Effectiveness of co-trimoxazole to prevent Plasmodium falciparum malaria in HIV-positive pregnant women in sub-Saharan Africa: an open-label, randomized controlled trial.
Klement E; Pitché P; Kendjo E; Singo A; D'Almeida S; Akouete F; Akpaloo Y; Tossa K; Prince-Agbodjan S; Patassi A; Caumes E
Clin Infect Dis; 2014 Mar; 58(5):651-9. PubMed ID: 24336820
[TBL] [Abstract][Full Text] [Related]
5. Placental malaria among HIV-infected and uninfected women receiving anti-folates in a high transmission area of Uganda.
Newman PM; Wanzira H; Tumwine G; Arinaitwe E; Waldman S; Achan J; Havlir D; Rosenthal PJ; Dorsey G; Clark TD; Cohan D
Malar J; 2009 Nov; 8():254. PubMed ID: 19912657
[TBL] [Abstract][Full Text] [Related]
6. Protecting pregnant women from malaria in areas of high HIV infection prevalence.
Meshnick SR; Mwapasa V; Rogerson SJ
J Infect Dis; 2006 Aug; 194(3):273-5. PubMed ID: 16826473
[No Abstract] [Full Text] [Related]
7. Insights Into Circulating Cytokine Dynamics During Pregnancy in HIV-Infected Beninese Exposed to Plasmodium falciparum Malaria.
Ibitokou SA; Denoeud-Ndam L; Ezinmegnon S; Ladékpo R; Zannou DM; Massougbodji A; Girard PM; Cot M; Luty AJ; Ndam NT
Am J Trop Med Hyg; 2015 Aug; 93(2):287-92. PubMed ID: 26101276
[TBL] [Abstract][Full Text] [Related]
8. Pharmacokinetics of mefloquine and its effect on sulfamethoxazole and trimethoprim steady-state blood levels in intermittent preventive treatment (IPTp) of pregnant HIV-infected women in Kenya.
Green M; Otieno K; Katana A; Slutsker L; Kariuki S; Ouma P; González R; Menendez C; ter Kuile F; Desai M
Malar J; 2016 Jan; 15():7. PubMed ID: 26732683
[TBL] [Abstract][Full Text] [Related]
9. Effect of trimethoprim-sulphamethoxazole on the risk of malaria in HIV-infected Ugandan children living in an area of widespread antifolate resistance.
Gasasira AF; Kamya MR; Ochong EO; Vora N; Achan J; Charlebois E; Ruel T; Kateera F; Meya DN; Havlir D; Rosenthal PJ; Dorsey G
Malar J; 2010 Jun; 9():177. PubMed ID: 20573194
[TBL] [Abstract][Full Text] [Related]
10. Safety and efficacy of co-trimoxazole for treatment and prevention of Plasmodium falciparum malaria: a systematic review.
Manyando C; Njunju EM; D'Alessandro U; Van Geertruyden JP
PLoS One; 2013; 8(2):e56916. PubMed ID: 23451110
[TBL] [Abstract][Full Text] [Related]
11. Randomized trial of 2-dose versus monthly sulfadoxine-pyrimethamine intermittent preventive treatment for malaria in HIV-positive and HIV-negative pregnant women in Malawi.
Filler SJ; Kazembe P; Thigpen M; Macheso A; Parise ME; Newman RD; Steketee RW; Hamel M
J Infect Dis; 2006 Aug; 194(3):286-93. PubMed ID: 16826475
[TBL] [Abstract][Full Text] [Related]
12. Cotrimoxazole prophylaxis versus mefloquine intermittent preventive treatment to prevent malaria in HIV-infected pregnant women: two randomized controlled trials.
Denoeud-Ndam L; Zannou DM; Fourcade C; Taron-Brocard C; Porcher R; Atadokpede F; Komongui DG; Dossou-Gbete L; Afangnihoun A; Ndam NT; Girard PM; Cot M
J Acquir Immune Defic Syndr; 2014 Feb; 65(2):198-206. PubMed ID: 24220287
[TBL] [Abstract][Full Text] [Related]
13. Predicting Optimal Dihydroartemisinin-Piperaquine Regimens to Prevent Malaria During Pregnancy for Human Immunodeficiency Virus-Infected Women Receiving Efavirenz.
Wallender E; Vucicevic K; Jagannathan P; Huang L; Natureeba P; Kakuru A; Muhindo M; Nakalembe M; Havlir D; Kamya M; Aweeka F; Dorsey G; Rosenthal PJ; Savic RM
J Infect Dis; 2018 Mar; 217(6):964-972. PubMed ID: 29272443
[TBL] [Abstract][Full Text] [Related]
14. Challenges in the concurrent management of malaria and HIV in pregnancy in sub-Saharan Africa.
Brentlinger PE; Behrens CB; Micek MA
Lancet Infect Dis; 2006 Feb; 6(2):100-11. PubMed ID: 16439330
[TBL] [Abstract][Full Text] [Related]
15. Malaria prevention during pregnancy-is there a next step forward?
Steketee RW
PLoS Med; 2014 Sep; 11(9):e1001734. PubMed ID: 25247816
[TBL] [Abstract][Full Text] [Related]
16. Malaria and HIV co-infection in pregnancy in sub-Saharan Africa: impact of treatment using antimalarial and antiretroviral agents.
Uneke CJ; Ogbonna A
Trans R Soc Trop Med Hyg; 2009 Aug; 103(8):761-7. PubMed ID: 18707747
[TBL] [Abstract][Full Text] [Related]
17. Malaria in pregnancy.
Whitty CJ; Edmonds S; Mutabingwa TK
BJOG; 2005 Sep; 112(9):1189-95. PubMed ID: 16101595
[TBL] [Abstract][Full Text] [Related]
18. Sulfamethoxazole Levels in HIV-Exposed Uninfected Ugandan Children.
Kasule J; Gabriel EE; Anok A; Neal J; Eastman RT; Penzak S; Newell K; Serwadda D; Duffy PE; Reynolds SJ; Hobbs CV
Am J Trop Med Hyg; 2018 Jun; 98(6):1718-1721. PubMed ID: 29692311
[TBL] [Abstract][Full Text] [Related]
19. Protective efficacy of co-trimoxazole prophylaxis against malaria in HIV exposed children in rural Uganda: a randomised clinical trial.
Sandison TG; Homsy J; Arinaitwe E; Wanzira H; Kakuru A; Bigira V; Kalamya J; Vora N; Kublin J; Kamya MR; Dorsey G; Tappero JW
BMJ; 2011 Mar; 342():d1617. PubMed ID: 21454456
[TBL] [Abstract][Full Text] [Related]
20. Placental malaria, maternal HIV infection and infant morbidity.
Briand V; Badaut C; Cot M
Ann Trop Paediatr; 2009 Jun; 29(2):71-83. PubMed ID: 19460261
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
